Intranasal Powder Administration of a Spray-Dried Tuberculosis Vaccine Candidate Characterized using the Alberta Idealized Nasal Inlet
Murphy B, Aisenstat M, Ordoubadi M, Tavernini S, Duong K, Zheng J, Whittal R, Sauvageau D, Fox CB, Finlay WH, Vehring R, Martin AR.
Respiratory Drug Delivery 2022. Volume , 2022: 441-446.
I have a subscription
Log in for instant access.
I do not have a subscription
Purchase Article (in PDF format)
